Search Results - "Autenrieth, Michael"

Treatment of carcinoma in situ of the urinary bladder with an alpha-emitter immunoconjugate targeting the epidermal growth factor receptor: a pilot study by Autenrieth, Michael E., Seidl, Christof, Bruchertseifer, Frank, Horn, Thomas, Kurtz, Florian, Feuerecker, Benedikt, D’Alessandria, Calogero, Pfob, Christian, Nekolla, Stephan, Apostolidis, Christos, Mirzadeh, Saed, Gschwend, Jürgen E., Schwaiger, Markus, Scheidhauer, Klemens, Morgenstern, Alfred

“…Purpose Patients with carcinoma in situ (CIS) of the bladder refractory to bacillus Calmette-Guérin (BCG) treatment are usually treated with cystectomy…”
Get full text

Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme by Ohashi, Riuko, Martignoni, Guido, Hartmann, Arndt, Caliò, Anna, Segala, Diego, Stöhr, Christine, Wach, Sven, Erlmeier, Franziska, Weichert, Wilko, Autenrieth, Michael, Schraml, Peter, Rupp, Niels J., Ohe, Chisato, Otsuki, Yoshiro, Kawasaki, Takashi, Kobayashi, Hiroshi, Kobayashi, Kazuhiro, Miyazaki, Tatsuhiko, Shibuya, Hiroyuki, Usuda, Hiroyuki, Umezu, Hajime, Fujishima, Fumiyoshi, Furusato, Bungo, Osakabe, Mitsumasa, Sugai, Tamotsu, Kuroda, Naoto, Tsuzuki, Toyonori, Nagashima, Yoji, Ajioka, Yoichi, Moch, Holger

“…A histological grading system of chromophobe renal cell carcinoma (chRCC) is highly desirable to identify approximately 5–10% of tumors at risk for…”
Get full text

PD-1/PD-L1 expression in chromophobe renal cell carcinoma: An immunological exception? by Erlmeier, Franziska, Hartmann, Arndt, Autenrieth, Michael, Wiedemann, Max, Ivanyi, Philipp, Steffens, Sandra, Weichert, Wilko

“…Immune checkpoint inhibitors targeting the inhibitory cross talk between tumor and immune cells have been approved for therapy in renal cell carcinoma (RCC)…”
Get full text

Immunohistochemical expression of the hepatocyte growth factor in chromophobe renal cell carcinoma by Erlmeier, Maximilian, Mikuteit, Marie, Zschäbitz, Stefanie, Autenrieth, Michael, Weichert, Wilko, Hartmann, Arndt, Steffens, Sandra, Erlmeier, Franziska

“…The prognostic value of Hepatocyte growth factor (HGF) in non-clear cell renal cell carcinoma (RCC) is still unclear. The aim of this study is to evaluate the…”
Get full text

Topography of Lymph Node Metastases in Prostate Cancer Patients Undergoing Radical Prostatectomy and Extended Lymphadenectomy: Results of a Combined Molecular and Histopathologic Mapping Study by Heck, Matthias M, Retz, Margitta, Bandur, Miriam, Souchay, Marc, Vitzthum, Elisabeth, Weirich, Gregor, Mollenhauer, Martin, Schuster, Tibor, Autenrieth, Michael, Kübler, Hubert, Maurer, Tobias, Thalgott, Mark, Herkommer, Kathleen, Gschwend, Jürgen E, Nawroth, Roman

“…Abstract Background To determine the anatomic extent of pelvic lymph node dissection (PLND) in prostate cancer (PCa) patients at the time of radical…”
Get full text

The synergism of spatial metabolomics and morphometry improves machine learning‐based renal tumour subtype classification by Prade, Verena M., Sun, Na, Shen, Jian, Feuchtinger, Annette, Kunzke, Thomas, Buck, Achim, Schraml, Peter, Moch, Holger, Schwamborn, Kristina, Autenrieth, Michael, Gschwend, Jürgen E., Erlmeier, Franziska, Hartmann, Arndt, Walch, Axel

“…Tumours of the kidney are a heterogeneous group of various types of cancer with characteristic histologic or genetic features that require tumour type-specific…”
Get full text

Virtual skills-training in urology : Teaching at the Technical University of Munich during the COVID-19-pandemic by Kidess, Marc, Schmid, Sebastian C, Pollak, Sebastian, Gschwend, Jürgen E, Berberat, Pascal O, Autenrieth, Michael E

“…The COVID-19 pandemic presents the challenge for medical education to teach practical skills without practical training. To provide an alternative to hands-on…”
Get full text

The Subject, Its Biology, and the Chronic Recurrent Cystitis by Noll-Hussong, Michael, Autenrieth, Michael, Pokorny, Dan, Herberger, Simone, Huber, Dorothea

“…Functional disorders in urology are troubling for both patients and physicians. Moreover, advances in recent research promise to provide biological insights…”
Get full text

Expression of Nectin-4 in Chromophobe Renal Cell Carcinoma in a Multicenter Cohort: Early Prognostic and Therapeutic Considerations by Mikuteit, Marie, Zschäbitz, Stefanie, Autenrieth, Michael, Weichert, Wilko, Hartmann, Arndt, Steffens, Sandra, Erlmeier, Franziska

“…Nectin-4 is a member of the nectin family and a calcium-independent immunoglobulin-like transmembrane protein that contributes to tumor growth and angiogenesis…”
Get more information

The role of claudin-6 in chromophobe renal cell carcinoma by Erlmeier, Franziska, Zschäbitz, Stefanie, Mikuteit, Marie, Autenrieth, Michael, Weichert, Wilko, Hartmann, Arndt, Steffens, Sandra

“…The prognostic value of Claudin-6 (CLDN6) in non clear cell renal cell carcinoma (RCC) is still unclear. To evaluate the prognostic impact of CLDN6 expression…”
Get full text

Growth Arrest-Specific 6 in Chromophobe Renal Cell Carcinoma by Mikuteit, Marie, Zschäbitz, Stefanie, Erlmeier, Maximilian, Autenrieth, Michael, Weichert, Wilko, Hartmann, Arndt, Steffens, Sandra, Erlmeier, Franziska

“…Overexpression of tumor-associated growth arrest-specific protein 6 (Gas6) is found in many tumor entities. The prognostic value of Gas6 in renal cell…”
Get more information

Prognostic impact of PD-1 and its ligands in renal cell carcinoma by Erlmeier, Franziska, Weichert, Wilko, Schrader, Andres Jan, Autenrieth, Michael, Hartmann, Arndt, Steffens, Sandra, Ivanyi, Philipp

“…Programmed death-1 receptor (PD-1) and programmed death-1 receptor-ligand (PD-L1) have been suggested to play a role as prognostic markers in clear cell renal…”
Get full text

Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging: Diagnostic Pathways and Metabolites for Renal Tumor Entities by Erlmeier, Franziska, Sun, Na, Shen, Jian, Feuchtinger, Annette, Buck, Achim, Prade, Verena M, Kunzke, Thomas, Schraml, Peter, Moch, Holger, Autenrieth, Michael, Weichert, Wilko, Hartmann, Arndt, Walch, Axel

“…Correct tumor subtyping of primary renal tumors is essential for treatment decision in daily routine. Most of the tumors can be classified based on morphology…”
Get more information

Ultrasound-based “CEUS-Bosniak”classification for cystic renal lesions: an 8-year clinical experience by Herms, Elena, Weirich, Gregor, Maurer, Tobias, Wagenpfeil, Stefan, Preuss, Stephanie, Sauter, Andreas, Heck, Matthias, Gärtner, Anita, Hauner, Katharina, Autenrieth, Michael, Kübler, Hubert P., Holzapfel, Konstantin, Schwarz-Boeger, Ulrike, Heemann, Uwe, Slotta-Huspenina, Julia, Stock, Konrad Friedrich

“…Purpose Renal cysts comprise benign and malignant entities. Risk assessment profits from CT/MRI imaging using the Bosniak classification. While Bosniak-IIF,…”
Get full text

MALDI Mass Spectrometry Imaging-Prognostic Pathways and Metabolites for Renal Cell Carcinomas by Erlmeier, Franziska, Sun, Na, Shen, Jian, Feuchtinger, Annette, Buck, Achim, Prade, Verena M, Kunzke, Thomas, Schraml, Peter, Moch, Holger, Autenrieth, Michael, Weichert, Wilko, Hartmann, Arndt, Walch, Axel

“…High mass resolution matrix-assisted laser desorption/ionization (MALDI) mass spectrometry imaging (MSI) is a suitable method for biomarker detection for…”
Get full text

Supremacy of modern morphometry in typing renal oncocytoma and malignant look-alikes by Erlmeier, Franziska, Feuchtinger, Annette, Borgmann, Daniela, Rudelius, Martina, Autenrieth, Michael, Walch, Axel Karl, Weirich, Gregor

“…In the era of tumour type-specific therapies, the correct typing of renal tumours is of prime importance. As immunotyping and genotyping approaches are…”
Get full text

PD-L2: A prognostic marker in chromophobe renal cell carcinoma? by Erlmeier, Franziska, Weichert, Wilko, Autenrieth, Michael, Wiedemann, Max, Schrader, Andres Jan, Hartmann, Arndt, Ivanyi, Philipp, Steffens, Sandra

“…In the context of cancer immunotherapy, PD-1 as well as PD-L1 has been widely studied in renal cell carcinoma (RCC). PD-1 and PD-L1 play a significant role as…”
Get full text

PD38-09 MOLECULAR LYMPH NODE ANALYSIS PROVIDES SUPERIOR PROGNOSTIC INFORMATION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND EXTENDED PELVIC LYMPH NODE DISSECTION IN COMPARISON WITH STANDARD HISTOPATHOLOGY by Heck, Matthias, Retz, Margitta, Bandur, Miriam, Souchay, Marc, Vitzthum, Elisabeth, Weirich, Gregor, Schuster, Tibor, Autenrieth, Michael, Kübler, Hubert, Maurer, Tobias, Thalgott, Mark, Herkommer, Kathleen, Gschwend, Jürgen, Nawroth, Roman

Get full text

Molecular Lymph Node Status for Prognostic Stratification of Prostate Cancer Patients Undergoing Radical Prostatectomy with Extended Pelvic Lymph Node Dissection by Heck, Matthias M, Retz, Margitta, Bandur, Miriam, Souchay, Marc, Vitzthum, Elisabeth, Weirich, Gregor, Schuster, Tibor, Autenrieth, Michael, Kübler, Hubert, Maurer, Tobias, Thalgott, Mark, Herkommer, Kathleen, Gschwend, Jürgen E, Nawroth, Roman

“…Molecular lymph node (LN) analysis using quantitative polymerase chain reaction (qPCR) detects LN metastases with higher sensitivity than histopathology…”
Get full text

Fractionated intravesical radioimmunotherapy with (213)Bi-anti-EGFR-MAb is effective without toxic side-effects in a nude mouse model of advanced human bladder carcinoma by Fazel, Julia, Rötzer, Silvia, Seidl, Christof, Feuerecker, Benedikt, Autenrieth, Michael, Weirich, Gregor, Bruchertseifer, Frank, Morgenstern, Alfred, Senekowitsch-Schmidtke, Reingard

“…Gold standard in therapy of superficial, non-muscle invasive urothelial tumors is transurethral resection followed by intravesical instillation therapies…”
Get full text